These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2672263)

  • 1. Use of fluoroquinolones for intracellular pathogens.
    Pocidalo JJ
    Rev Infect Dis; 1989; 11 Suppl 5():S979-84. PubMed ID: 2672263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Legionella pneumophila in guinea pig peritoneal macrophages by new quinolone, macrolide and other antimicrobial agents.
    Kitsukawa K; Hara J; Saito A
    J Antimicrob Chemother; 1991 Mar; 27(3):343-53. PubMed ID: 2037540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of the quinolones in the treatment of legionellosis.
    Meyer RD
    J Antimicrob Chemother; 1991 Nov; 28(5):623-5. PubMed ID: 1778869
    [No Abstract]   [Full Text] [Related]  

  • 4. [Are quinolones the drugs of choice in pneumonia caused by microorganisms of Legionella genus?].
    Bouza Santiago E; Rodríguez-Créixems M
    Enferm Infecc Microbiol Clin; 1999; 17 Suppl 1():19-23. PubMed ID: 10563106
    [No Abstract]   [Full Text] [Related]  

  • 5. BMS-284756 (T-3811ME) a new fluoroquinolone: in vitro activity against Legionella, efficacy in a guinea pig model of L. pneumophila pneumonia and pharmacokinetics in guinea pigs.
    Edelstein PH; Shinzato T; Edelstein MA
    J Antimicrob Chemother; 2001 Nov; 48(5):667-75. PubMed ID: 11679556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-vitro activities of gatifloxacin, sparfloxacin and trovafloxacin against 103 strains of Legionella spp.
    Croco MA; Biedenbach DJ; Pfaller MA; Doern GV; Jones RN
    J Antimicrob Chemother; 1998 Nov; 42(5):672-3. PubMed ID: 9848457
    [No Abstract]   [Full Text] [Related]  

  • 7. Antibacterial activities of gemifloxacin, levofloxacin, gatifloxacin, moxifloxacin and erythromycin against intracellular Legionella pneumophila and Legionella micdadei in human monocytes.
    Baltch AL; Bopp LH; Smith RP; Michelsen PB; Ritz WJ
    J Antimicrob Chemother; 2005 Jul; 56(1):104-9. PubMed ID: 15941776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activity of quinolones, macrolides and ketolides against Legionella species using in vitro broth dilution and intracellular susceptibility testing.
    Stout JE; Sens K; Mietzner S; Obman A; Yu VL
    Int J Antimicrob Agents; 2005 Apr; 25(4):302-7. PubMed ID: 15784309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinolones in the treatment of lower respiratory tract infections caused by intracellular pathogens.
    Chidiac C; Mouton Y
    Infection; 1991; 19 Suppl 7():S365-71. PubMed ID: 1804785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity and post-antibiotic effect of gemifloxacin against Legionella spp.
    Dubois J; St-Pierre C
    J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():41-6. PubMed ID: 10824031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Legionella pneumophila multiplication within human macrophages by fleroxacin.
    Pohlod DJ; Saravolatz LD; Somerville MM
    J Antimicrob Chemother; 1988 Oct; 22 Suppl D():49-54. PubMed ID: 3144549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rufloxacin (MF-934): in vitro and in vivo antibacterial activity.
    Ravizzola G; Pinsi G; Pirali F; Colombrita D; Foresti I; Peroni L; Turano A
    Drugs Exp Clin Res; 1989; 15(1):11-5. PubMed ID: 2743869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pneumonia due to Legionella. Macrolides or quinolones?].
    Gómez J; Ruiz Gómez J; Sabrià M
    Rev Esp Quimioter; 2002 Mar; 15(1):21-4. PubMed ID: 12582433
    [No Abstract]   [Full Text] [Related]  

  • 14. Laboratory survey of fluoroquinolone activity.
    Bellido F; Pechère JC
    Rev Infect Dis; 1989; 11 Suppl 5():S917-24. PubMed ID: 2672262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activities of tigecycline and comparators against Legionella pneumophila and Legionella micdadei extracellularly and in human monocyte-derived macrophages.
    Bopp LH; Baltch AL; Ritz WJ; Michelsen PB; Smith RP
    Diagn Microbiol Infect Dis; 2011 Jan; 69(1):86-93. PubMed ID: 21146719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of severe respiratory infection. Legionella pneumonia].
    Saito A
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Mar; 27(3):281-5. PubMed ID: 2615084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of pazufloxacin, tosufloxacin and other quinolones against Legionella species.
    Higa F; Akamine M; Haranaga S; Tohyama M; Shinzato T; Tateyama M; Koide M; Saito A; Fujita J
    J Antimicrob Chemother; 2005 Dec; 56(6):1053-7. PubMed ID: 16260445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a human monocytic cell line THP-1 model for assay of the intracellular activities of antimicrobial agents against Legionella pneumophila.
    Takemura H; Yamamoto H; Kunishima H; Ikejima H; Hara T; Kanemitsu K; Terakubo S; Shoji Y; Kaku M; Shimada J
    J Antimicrob Chemother; 2000 Oct; 46(4):589-94. PubMed ID: 11020257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity of sparfloxacin (AT-4140), PD127391 and PD131628 against Legionella spp.
    Jones RN
    J Antimicrob Chemother; 1991 Mar; 27(3):389-90. PubMed ID: 2037543
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.